Latest Share Chat

REMOVE ADS

Renalytix Plc Share News (RENX)

Renalytix Plc Information

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes

Get Live Data

1.85 0.00 (0.00%)

Bid:

1.70

Ask:

2.00

Spread: 0.30 (17.647%)

Market Cap: £8.08m

Last checked at -

Intraday Renalytix Plc Share Chart

REMOVE ADS

Renalytix Plc News

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial ...

Renalytix AI Starts Collaboration With Dutch University Medical Centre

LONDON (Alliance News) - Renalytix AI PLC on Tuesday said it commenced a collaboration with University Medical Center Groningen to evaluate KidneyInte...

Renalytix Kidney Disease Prediction Tool Beats Current Models In Study

LONDON (Alliance News) - Renalytix AI PLC on Monday said a recent study showed that combining its three biomarkers along with health records data impr...

Renalytix AI Posts Interim Loss Ahead Of KidneyIntelX 2019 Launch

LONDON (Alliance News) - Renalytix AI PLC on Monday posted a loss for the first half of its financial year due to administrative expenses as it prepar...

Renalytix Sets Up Panel Of Experts To Support Kidney Transplant Work

LONDON (Alliance News) - Renalytix AI PLC on Friday announced the set up of a core investigator group for a kidney transplant diagnostic programme.Ren...

Renalytix AI begins clinical validation study for 'KidneyIntelX'

(Sharecast News) - Artificial intelligence-enabled kidney disease diagnostics developer Renalytix AI announced the start of its clinical validation st...

Renalytix AI Starts Validation Study For Kidney Disease Diagnostic

LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has started a clinical validation study of KidneyIntelX for diagnosing fast-progressing...

Renalytix Exercises Option For Kidney Transplant Diagnostic Technology

LONDON (Alliance News) - Renalytix AI PLC said Wednesday that it has exercised an option to secure the exclusive licence for kidney transplant diagnos...